title: Kinetics of Respiratory Syncytial Virus (RSV) Memphis Strain 37 (M37) Infection in the Respiratory Tract of Newborn Lambs as an RSV Infection Model for Human Infants.
abstract: BACKGROUND
  Respiratory syncytial virus (RSV) infection in preterm and newborn infants can result in severe bronchiolitis and hospitalization. The lamb lung has several key features conducive to modeling RSV infection in human infants, including susceptibility to human strains of RSV such as the A2, Long, and Memphis Strain 37 (M37). In this study, the kinetics of M37 infection was investigated in newborn lambs in order to better define clinical, viral, physiological, and immunological parameters as well as the pathology and lesions.
  
  
  METHODS
  Newborn lambs were nebulized with M37 hRSV (6 mL of 1.27 x 10(7) FFU/mL), monitored daily for clinical responses, and respiratory tissues were collected from groups of lambs at days 1, 3, 4, 6, and 8 post-inoculation for the assessment of viral replication parameters, lesions and also cellular, immunologic and inflammatory responses.
  
  
  RESULTS
  Lambs had increased expiratory effort (forced expiration) at days 4, 6, and 8 post-inoculation. Nasal wash lacked RSV titers at day 1, but titers were present at low levels at days 3 (peak), 4, and 8. Viral titers in bronchoalveolar lavage fluid (BALF) reached a plateau at day 3 (4.6 Log10 FFU/mL), which was maintained until day 6 (4.83 Log10 FFU/mL), and were markedly reduced or absent at day 8. Viral RNA levels (detected by RT-qPCR) in BALF were indistinguishable at days 3 (6.22 ± 0.08 Log10 M37 RNA copies/mL; mean ± se) and 4 (6.20 ± 0.16 Log10 M37 RNA copies/mL; mean ± se) and increased slightly on day 6 (7.15 ± 0.2 Log10 M37 RNA copies/mL; mean ± se). Viral antigen in lung tissue as detected by immunohistochemistry was not seen at day 1, was present at days 3 and 4 before reaching a peak by day 6, and was markedly reduced by day 8. Viral antigen was mainly present in airways (bronchi, bronchioles) at day 3 and was increasingly present in alveolar cells at days 4 and 6, with reduction at day 8. Histopathologic lesions such as bronchitis/bronchiolitis, epithelial necrosis and hyperplasia, peribronchial lymphocyte infiltration, and syncytial cells, were consistent with those described previously for lambs and infants.
  
  
  CONCLUSIONS
  This work demonstrates that M37 hRSV replication in the lower airways of newborn lambs is robust with peak replication on day 3 and sustained until day 6. These findings, along with the similarities of lamb lung to those of infants in terms of alveolar development, airway branching and epithelium, susceptibility to human RSV strains, lesion characteristics (bronchiolitis), lung size, clinical parameters, and immunity, further establish the neonatal lamb as a model with key features that mimic RSV infection in infants.
authors.affiliation: Department of Veterinary Pathology, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Larios Mora
authors.affiliation: Ablynx NV, Zwijnaarde, Belgium.
authors.forename: Laurent
authors.initials: L
authors.lastname: Detalle
authors.affiliation: Department of Veterinary Pathology, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Albert
authors.initials: A
authors.lastname: Van Geelen
authors.affiliation: Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma, United States of America.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Davis
authors.affiliation: Ablynx NV, Zwijnaarde, Belgium.
authors.forename: Thomas
authors.initials: T
authors.lastname: Stohr
authors.affiliation: Department of Veterinary Pathology, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Jack M
authors.initials: JM
authors.lastname: Gallup
authors.affiliation: Department of Veterinary Pathology, Iowa State University, Ames, Iowa, United States of America.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Ackermann
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D000956:Antigens, Viral / Q000378:metabolism; D001992:Bronchoalveolar Lavage Fluid / Q000821:virology; D018925:Chemokines / Q000235:genetics; D016207:Cytokines / Q000235:genetics; D004195:Disease Models, Animal; D005814:Genes, Viral; D006801:Humans; D007231:Infant, Newborn; D007700:Kinetics; D008168:Lung / Q000276:immunology / Q000473:pathology / Q000821:virology; D012367:RNA, Viral / Q000235:genetics / Q000378:metabolism; D018357:Respiratory Syncytial Virus Infections / Q000209:etiology / Q000473:pathology / Q000821:virology*; D018113:Respiratory Syncytial Virus, Human / Q000235:genetics / Q000472:pathogenicity* / Q000502:physiology*; D034561:Sheep, Domestic; D014779:Virus Replication
chemical_list: D000956:Antigens, Viral; D018925:Chemokines; D016207:Cytokines; D012367:RNA, Viral